(Q54117981)

25 May 2018

title

Pharmacokinetics of ramipril in hypertensive patients with renal insufficiency. (English)

1 reference

25 May 2018

1 reference

H Schunkert

1

1 reference

25 May 2018

J Kindler

2

1 reference

25 May 2018

M Gassmann

3

1 reference

25 May 2018

W Lahn

4

1 reference

25 May 2018

R Irmisch

5

1 reference

25 May 2018

E Ritz

6

1 reference

25 May 2018

E R Debusmann

7

1 reference

25 May 2018

J O Pujadas

8

1 reference

25 May 2018

K M Koch

9

1 reference

25 May 2018

H G Sieberth

10

1 reference

25 May 2018

publication date

1 January 1989

1 reference

25 May 2018

European Journal of Clinical Pharmacology

published in

1 reference

25 May 2018

volume

37

1 reference

25 May 2018

issue

3

1 reference

25 May 2018

page(s)

249-256

1 reference

25 May 2018

https://scigraph.springernature.com/pub.10.1007/bf00679779

exact match

0 references

cites work

Clinical pharmacokinetics of the angiotensin converting enzyme inhibitors. A review

1 reference

12 December 2020

Acute hemodynamic, hormonal and electrolyte effects of ramipril in severe congestive heart failure

1 reference

12 December 2020

Influence of renal function on the pharmacokinetics of ramipril (HOE 498)

1 reference

12 December 2020

The effect of renal function on enalapril kinetics

1 reference

12 December 2020

Enalapril maleate and a lysine analogue (MK-521): disposition in man

1 reference

12 December 2020

Short- and long-term effects of ramipril in hypertension.

1 reference

12 December 2020

Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of a novel orally active angiotensin converting enzyme inhibitor (HOE 498) in healthy subjects

1 reference

12 December 2020

Renal handling of captopril: effect of probenecid

1 reference

12 December 2020

ANTIHYPERTENSIVE EFFECT OF THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME INHIBITOR "MK-421"

1 reference

12 December 2020

Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of ramipril in renal failure

1 reference

12 December 2020

Effects of enalapril, a new converting enzyme inhibitor, in hypertension

1 reference

12 December 2020

Pharmacokinetics of repeated single oral doses of enalapril maleate (mk-421) in normal volunteers

1 reference

12 December 2020

Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition

1 reference

12 December 2020

[Serum creatinine determination without protein precipitation]

1 reference

12 December 2020

Pharmacokinetics and biotransformation of 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S, 5S)-2-azabicyclo [3.3.0]octane-3-carboxylic acid (Hoe 498) in rat, dog and man

1 reference

12 December 2020

Pharmacokinetics of captopril in healthy subjects and in patients with cardiovascular diseases

1 reference

12 December 2020

Enalapril maleate (MK-421), a potent, nonsulfhydryl angiotensin-converting enzyme inhibitor: absorption, disposition, and metabolism in man

1 reference

12 December 2020

Sustained Effectiveness of Converting-Enzyme Inhibition in Patients with Severe Congestive Heart Failure

1 reference

12 December 2020

A radioimmunoassay for the angiotensin converting enzyme inhibitor ramipril and its active metabolite

1 reference

12 December 2020

1 reference

12 December 2020

Pharmacokinetics of enalapril in normal subjects and patients with renal impairment

1 reference

12 December 2020

Ramipril: review of pharmacology

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00679779

1 reference

25 May 2018

1 reference

25 May 2018